Related Experiment Video
Updated: Jun 3, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Rhythm Control Better Prevents Stroke than Rate Control in Patients with Concomitant Hypertrophic Cardiomyopathy and
Shang-Ju Wu1,2, Yun-Yu Chen1,3,4, Yu-Shan Chien1,2,5,6
1Cardiovascular Center, Taichung Veterans General Hospital, Taichung.
Insights
Rhythm control therapy significantly reduced stroke risk in patients with atrial fibrillation (AF) and hypertrophic cardiomyopathy (HCM). This approach, primarily using medication, proved more effective than rate control for stroke prevention in long-term follow-up.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Atrial fibrillation (AF) is a known risk factor for stroke and mortality.
- The impact of rhythm control on stroke risk in patients with concomitant hypertrophic cardiomyopathy (HCM) is not well-established.
Purpose of the Study:
- To investigate whether rhythm control therapy reduces stroke risk in patients diagnosed with both atrial fibrillation and hypertrophic cardiomyopathy.
- To compare the effectiveness of rhythm control versus rate control strategies in preventing adverse cardiovascular events in this patient population.
Main Methods:
- A cohort of 178 adult patients with both AF and HCM was identified from the Taiwan National Health Insurance Database.
- Patients were categorized into rhythm control (antiarrhythmic medications or catheter ablation) or rate control (rate-controlling medications) groups.
- A multivariable Cox regression model was employed to assess the hazard ratio for adverse cardiovascular events, including stroke.
Main Results:
- The rhythm control group (99 patients) demonstrated a significantly lower risk of stroke compared to the rate control group (79 patients) over a mean follow-up of 6.47 years (adjusted HR: 0.380, p = 0.031).
- This stroke risk reduction benefit persisted even after excluding patients who underwent catheter ablation (adjusted HR: 0.380, p = 0.037).
- The protective effect of rhythm control on stroke risk was independent of oral anticoagulant use.
Conclusions:
- Rhythm control, primarily through pharmacological means, is more effective than rate control in preventing stroke among patients with both AF and HCM.
- The findings suggest a long-term benefit of maintaining sinus rhythm in this specific patient cohort.
- Rhythm control offers a valuable strategy for mitigating stroke risk in patients with AF and HCM, irrespective of antithrombotic therapy.
Background:
Atrial fibrillation (AF) increases the risks of stroke and mortality. It remains unclear whether rhythm control reduces the risk of stroke in patients with AF concomitant with hypertrophic cardiomyopathy (HCM).
Methods:
We identified AF patients with HCM who were ≥ 18 years old in the Taiwan National Health Insurance Database. Patients using antiarrhythmic medications for ≥ 30 defined daily doses (DDDs) or receiving catheter ablation for AF constituted the rhythm control group. Patients using rate control medications for ≥ 30 DDDs constituted the rate control group. A multivariable Cox regression model was used to evaluate the hazard ratio (HR) for adverse cardiovascular events.
Results:
We enrolled a total of 178 patients with both AF and HCM without pre-existing cardiovascular diseases. Among them, 99 were in the rhythm control group and 79 were in the rate control group. After a follow-up period of 6.47 ± 0.98 years, the rhythm control group had a lower risk of stroke than the rate control group (adjusted HR: 0.380, p = 0.031) after adjusting for covariates including use of antithrombotic agents. After excluding patients receiving catheter ablation, the rhythm control group still had a lower risk of stroke than the rate control group (adjusted HR: 0.380, p = 0.037).
Conclusions:
In patients with AF and HCM, rhythm control with mainly pharmacological treatment better prevented stroke than rate control in long-term follow-up. The beneficial effect of lowering stroke risk through rhythm control was independent of oral anticoagulant use.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Mechanism of Cardiac Arrhythmias